Ad
related to: fast foundation for angelman syndrome therapeutics impact factor
Search results
Results from the WOW.Com Content Network
Angelman syndrome is a rare, incurable neurogenetic disorder that can cause intellectual disability, speech and balance problems, developmental delays and possible seizures, according to the Mayo ...
ALTO-100, previously known as NSI-189 (NeuralStem Inc. 189), [3] is a drug described as a hippocampal neurogenesis stimulant and indirect brain-derived neurotrophic factor (BDNF) modulator which is under development for the treatment of major depressive disorder (MDD), bipolar depression, and post-traumatic stress disorder (PTSD).
Colin Farrell reveals son's Angelman syndrome diagnosis. Colin Farrell, an Oscar-nominated actor, has launched the Colin Farrell Foundation, which is "committed to transforming the lives of ...
At the core of Farrell's new organization and its mission: the actor's 20-year-old son James, who lives with Angelman Syndrome. "I want the world to be kind to James," Farrell told People in an ...
The impact factor relates to a specific time period; it is possible to calculate it for any desired period. For example, the JCR also includes a five-year impact factor, which is calculated by dividing the number of citations to the journal in a given year by the number of articles published in that journal in the previous five years. [14] [15]
Diagnostic criteria for the disorder were initially established in 1995 in collaboration with the Angelman syndrome Foundation (US); [26] these criteria underwent revision in 2005. [ 27 ] Seizures are a consequence, as is excessive laughter, [ 28 ] which is a major hindrance to early diagnosis.
Colin Farrell is also an Angelman parent, and the actor recently started a foundation in honor of his son James, who turns 21 in September. James "has worked so hard all his life, so hard ...
This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.
Ad
related to: fast foundation for angelman syndrome therapeutics impact factor